Skip to content

Airway protection during video-assisted thoracoscopy using a larynx mask in spontaneous breathing compared to controlled ventilation with double lumen tube

Airway protection during video-assisted thoracoscopy using a larynx mask in spontaneous breathing compared to controlled ventilation with double lumen tube - LAMA-VATS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00018791
Enrollment
56
Registered
2020-01-15
Start date
2020-02-06
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients for video-assisted thoracoscopy

Interventions

Group 1: Control group: double lumen tube, regional pain procedure Group 2: Intervention Group: Laryngeal Mask, ESPB

Sponsors

Universitätsklinikum Leipzig
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. patients for video-assisted thoracoscopy: atypical wedge resections for round herd resection/securing, lung and pleural biopsies, bulllectomy and pleurodeses, the care of the uncomplicated early empyema for VATS decoration, lung tip resections and parietal pleurectomies for pneumothorax and talcum pleurodeses 2. there is a clinical indication to perform a regional pain procedure and the patient has agreed. 3. age from 18 years 4. written consent of the patient to the study has been obtained 5. ASA I-III 6. BMI </= 30

Exclusion criteria

Exclusion criteria: 1. heart failure NYHA >II 2. COPD > Gold II 3. patients with an increased risk of aspiration 4. lack of willingness to cooperate (compliance) 5. women during pregnancy and lactation 6. BMI >30 7. any neuromuscular disease 8. participation in other interventional studies within the last three months 9. pacemakers or other implanted pacemaker or stimulator systems

Design outcomes

Primary

MeasureTime frame
CoV (Center of Ventilation) in the EIT of the ventilated lung.

Secondary

MeasureTime frame
- Measurement of tidal variations (TIV) within the Regions of Interest (ROI) - Calculation of the GI (Global Inhomogeneity Index) in the EIT - paO2, paCO2, oxygenation index at defined measuring times - maximum intraoperative dose of norepinephrine in µg/kg bw/min) - Number of interventions in the LAMA group requiring secondary intubation (conversion rate to double lumen tube) and number of interventions requiring a change of procedure from DLT to laryngeal mask - postoperative pain level at the beginning and at discharge from the AWR/PACU, on the 1st POD, as well as at discharge from the hospital using NRS (pain) / recording of peaks and at rest - Rate of sore throat, hoarseness and difficulty swallowing using NRS 1-10 on discharge from the AWR, on the 1st POD, on discharge, on the 28th POD - perioperative process times in min (comparison of release time, release cut time, cut-suture time, suture to end of anaesthesia) -breathing frequency perioperative -OP conditions, assessment by surgery: NRS 1-10 - Percentage decrease in FEV1 and VC between preoperative evaluation of lung function (spirometry findings) preop. and at discharge - Frequency of pulmonary complications until discharge from the hospital and on the 28th postoperative day (type, number) -frequency of home oxygen therapy/LTOT supply preoperatively and on the 28th POD (in l/min, continuous or intermittent)

Countries

Germany

Contacts

Public ContactSven Bercker

Klinik und Poliklinik für Anästhesiologie und Intensivtherapie

sven.bercker@medizin.uni-leipzig.de+49 341 97 17700

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026